Skip to main content
. Author manuscript; available in PMC: 2012 May 9.
Published in final edited form as: J Cereb Blood Flow Metab. 2009 Jul 8;29(10):1714–1726. doi: 10.1038/jcbfm.2009.86

Figure 4. DCE MRI pharmacokinetic parameter estimates obtained in presence or in absence of USPIO.

Figure 4

The pharmacokinetic parameters obtained in Session 1 (USPIO−, black) and in Session 2 (USPIO+, gray) are represented as mean±SEM. Data obtained in the muscle have been pooled across tumor models (n=20) while data from the C6 tumor and the RG2 tumor were kept separated (n=14 and n=6 respectively).